Home FOR AUTHORS Neoplasma 2014 Neoplasma Vol.61, No.2, p.205-212, 2014

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.61, No.2, p.205-212, 2014

Title: Coexpression of IL-6 and TNF-α: prognostic significance on breast cancer outcome
Author: G. TRIPSIANIS, E. PAPADOPOULOU, K. ANAGNOSTOPOULOS, S. BOTAITIS, M. KATOTOMICHELAKIS, K. ROMANIDIS, E. KONTOMANOLIS, I. TENTES, A. KORTSARIS

Abstract:

Presented study was conducted to investigate the prognostic significance of the coexpression of serum interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) in breast cancer, by correlating their presence with clinicopathological characteristics indicative of tumor progression and the overall survival of breast cancer patients. One hundred twelve consecutive patients with primary breast cancer were prospectively included and evaluated. Serum concentrations of IL-6 and TNF-a were measured by quantitative sandwich enzyme immunoassay (ELISA). Median split was used to subdivide patients with low or high IL-6 and TNF-a levels. A positive association between the expression of the two cytokines was found.

The coexpression of high IL-6 and TNF-α was independently associated with extended lymph node (>3) involvement (aOR, 7.8) and lymphovascular invasion (aOR, 14.1), increasing the prognostic significance of each cytokine separately; it also provided additional prognostic information regarding survival, defining a high-risk subgroup of patients with significantly shorter survival and higher risk of death compared to patients with both cytokines low (aHR, 4.45) and patients with only one cytokine high (aHR, 3.63).

Our findings suggest that the coexpression of these two cytokines could be used clinically as a useful tumor marker for the extension and the outcome of the disease.



Keywords: IL-6, TNF-α, breast cancer, prognosis, metastasis, survival
Published online: 02-Dec-2013
Year: 2014, Volume: 61, Issue: 2 Page From: 205, Page To: 212
doi:10.4149/neo_2014_026


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.